Delayed-Onset ICI-Associated Myocarditis
Open Access
- 1 October 2025
- journal article
- case report
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (30) , 105307
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Updates in Diagnosis and Treatment of Immune Checkpoint Inhibitor MyocarditisCurrent Cardiology Reports, 2025
- Severe vs Nonsevere Immune Checkpoint Inhibitor-Induced MyocarditisJACC: Cardiooncology, 2023
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)European Heart Journal - Cardiovascular Imaging, 2022
- Cardiac MRI Features and Prognostic Value in Immune Checkpoint Inhibitor–induced MyocarditisRadiology, 2022
- Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor–Associated MyocarditisJAMA Cardiology, 2021
- Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse eventsJournal for ImmunoTherapy of Cancer, 2021
- Cardiovascular Magnetic Resonance in Nonischemic Myocardial InflammationJACC, 2018
- Immune-related adverse events with immune checkpoint blockade: a comprehensive reviewEuropean Journal of Cancer, 2016
- Cardiovascular Magnetic Resonance in Myocarditis: A JACC White PaperJACC, 2009
- Myocarditis: The Dallas criteriaHuman Pathology, 1987